First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1

Critical Care

Volumn 14, Issue 1, 2010, Pages

  de Castro, Isabel F ^a   Guzmán Fulgencio, María ^a   García Álvarez, Mónica ^a   Resino, Salvador ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

CYTOKINE STORM; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; INFLUENZA A (H1N1); INNATE IMMUNITY; NOTE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; BLOOD; CASE CONTROL STUDY; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; PATHOLOGY; VIROLOGY;

CASE-CONTROL STUDIES; CYTOKINES; HUMANS; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN;

EID: 77956631205     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8846     Document Type: Note

References (15)

1. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramírez P, Martin-Loeches I, Varillas D, Gallegos MC, Serón C, Micheloud D, Gomez JM, Tenorio-Abreu A, Ramos MJ, Molina ML, Huidobro S, Sanchez E, Gordón M, Fernández V, Del Castillo A, Marcos MA, Villanueva B, López CJ, Rodríguez-Domínguez M, Galan JC, Cantón R, Lietor A, Rojo S, Eiros JM, Hinojosa C, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009, 13:R201. 2811892, 20003352, 10.1186/cc8208.
2. Nicoll A, Coulombier D. Europe's initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices. Eur Surveill 2009, 14. 2811892, 20003352.
3. Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis 1999, 5:285-294.
4. Muraille E, Leo O. Revisiting the Th1/Th2 paradigm. Scand J Immunol 1998, 47:1-9.
5. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 1996, 80:225-235. 10.1006/clin.1996.0118, 8811042.
6. Bermejo-Martin JF, Garcia-Arevalo MC, Alonso A, De Lejarazu RO, Pino M, Resino S, Tenorio A, Bernardo D, Leon AJ, Garrote JA, Ardura J, Dominguez-Gil M, Eiros JM, Blanco-Quiros A, Munoz-Fernandez MA, Kelvin DJ, Arranz E. Persistence of proinflammatory response after severe respiratory syncytial virus disease in children. J Allergy Clin Immunol 2007, 119:1547-1550. 10.1016/j.jaci.2007.03.014, 17451801.
7. Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, Turner PV, Ran R, Danesh A, Fang Y, Chan PK, Mytle N, Sullivan TJ, Collins TL, Johnson MG, Medina JC, Rowe T, Kelvin DJ. Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. J Virol 2008, 82:11308-11317. 2573250, 18684821, 10.1128/JVI.00691-08.
8. Cameron MJ, Bermejo-Martin JF, Danesh A, Muller MP, Kelvin DJ. Human immunopathogenesis of severe acute respiratory syndrome (SARS). Virus Res 2008, 133:13-19. 10.1016/j.virusres.2007.02.014, 17374415.
9. Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, Muller MP, Gold WL, Richardson SE, Poutanen SM, Willey BM, DeVries ME, Fang Y, Seneviratne C, Bosinger SE, Persad D, Wilkinson P, Greller LD, Somogyi R, Humar A, Keshavjee S, Louie M, Loeb MB, Brunton J, McGeer AJ, Kelvin DJ. Canadian SARS Research Network Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 2007, 81:8692-8706. 1951379, 17537853, 10.1128/JVI.00527-07, Canadian SARS Research Network.
10. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Medods 2006, 12:1203-1207. 10.1038/nm1477, 20003352, 2811892.
11. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001, 12:171-180. 10.1016/S1359-6101(00)00026-5, 11325600.
12. Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008, 226:57-79. 10.1111/j.1600-065X.2008.00699.x, 19161416.
13. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009, 27:485-517. 10.1146/annurev.immunol.021908.132710, 19132915.
14. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI, Ross TM, Witztum JL, Kolls JK. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 2009, 183:5301-5310. 10.4049/jimmunol.0900995, 19783685.
15. Bermejo-Martin JF, Kelvin DJ, Eiros JM, Castrodeza J, Ortiz de Lejarazu R. Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains. J Infect Dev Ctries 2009, 3:159-161. 10.3855/jidc.18, 19759469.